Engineers Gate Manager’s VIVEVE MED INC VIVE Stock Holding History

Engineers Gate Manager’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,006	Closed	-$40K	–	2159
2021 Q1	$40K	Buy	+13,006	New	+$47.8K	﹤0.01%	1759

Other funds holding VIVE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Engineers Gate Manager's VIVE Position: Q2 2021 in Review

Engineers Gate Manager sold out of VIVEVE MED INC (VIVE) in Q2 2021, closing a stake of 13,006 shares — an estimated $40K sold.

Engineers Gate Manager first reported a position in VIVE in Q1 2021 and held it in 1 quarter. The position peaked at $40K in Q1 2021. 15 funds tracked by Wall St. Rank hold VIVE as of Q2 2021.

Engineers Gate Manager reported no remaining VIVEVE MED INC position as of Q2 2021 after selling out during the quarter.
Engineers Gate Manager sold 13,006 VIVEVE MED INC shares in Q2 2021, an estimated $40K.
Engineers Gate Manager first reported a position in VIVEVE MED INC in Q1 2021 and held it in 1 quarter.
Engineers Gate Manager's VIVEVE MED INC position peaked at $40K in Q1 2021.
15 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q2 2021.

Based on Engineers Gate Manager's 13F filing for Q2 2021, filed 16 Aug 2021.